A recent study reveals that patients who stop using popular slimming jabs like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who stop conventional lifestyle programs.
Published data in a prominent medical journal points out that while obese individuals often shed substantial amounts of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month upon discontinuation.
"Users buying such medications must be informed of the potential of quick rebound weight gain when the therapy concludes," warns expert Dr. Susan Jebb.
Such speed of regain implies a return to pre-treatment mass in about a year and a half.
Comparing Therapies
The study, which examined 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
Researchers note that individuals who shed pounds through dieting usually see a slower weight regain—perhaps 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists suggest the way of the drugs is key to understanding the amplified rebound.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making overeating far more likely."
An Ongoing Condition?
Health authorities recommend the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Professionals say that, due to the significant potential of relapse, the therapy might need to be ongoing.
This perspective is supported by drug manufacturers, who note that the findings "highlight the chronic nature of obesity," akin to managing conditions like high blood pressure.
User Testimonies
People who have come off the medication report a powerful resurgence of hunger.
"I experienced something activating and you become ravenous," said a patient.
The struggle is compounded if individuals have not established lasting dietary or behavioural changes during therapy.
Growing Interest
Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Use is more common among women compared to males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians stress that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and long-term success hinges on ongoing lifestyle support.
